Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Child-Pugh Class B”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Study completedNCT01188733
What this trial is testing

Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionEsophageal Varices
Mayo Clinic 39
Early research (Phase 1)Study completedNCT06957756
What this trial is testing

Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems

Who this might be right for
Hepatic Insufficiency
Boehringer Ingelheim 43
Early research (Phase 1)Not Yet RecruitingNCT06994572
What this trial is testing

Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Captor Therapeutics S.A. 141
Post-approval studies (Phase 4)Study completedNCT01846455
What this trial is testing

Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects

Who this might be right for
Hepatic FailureHepatic ImpairmentChronic Hepatitis C Infection With Hepatic Coma
Indivior Inc. 43
Large-scale testing (Phase 3)Ended earlyNCT01405573
What this trial is testing

Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma

Who this might be right for
Advanced Adult Hepatocellular Carcinoma
National Cancer Institute, Naples 35
Large-scale testing (Phase 3)UnknownNCT00921531
What this trial is testing

Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 200
Early research (Phase 1)Study completedNCT05088642
What this trial is testing

A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

Who this might be right for
Sever Aplastic Anaemia
Jiangsu HengRui Medicine Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT02201901
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 268
Early research (Phase 1)Study completedNCT06888115
What this trial is testing

The Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

Who this might be right for
Primary Biliary Cholangitis
Cascade Pharmaceuticals, Inc 24
Early research (Phase 1)Ended earlyNCT04136444
What this trial is testing

A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic Function

Who this might be right for
Healthy Study ParticipantsImpaired Hepatic Function
UCB Biopharma S.P.R.L. 12
Early research (Phase 1)Study completedNCT03846843
What this trial is testing

OCR002-SP103 - Oral Immediate Release Study

Who this might be right for
Cirrhosis
Ocera Therapeutics, Inc. 30
Large-scale testing (Phase 3)Ended earlyNCT02762266
What this trial is testing

Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

Who this might be right for
Child-Pugh Class AChild-Pugh Class BRecurrent Hepatocellular Carcinoma
Stanford University 13
Early research (Phase 1)Looking for participantsNCT07694843
What this trial is testing

A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function

Who this might be right for
Healthy ParticipantsParticipants With Mild Hepatic ImpairmentParticipants With Moderate Hepatic Impairment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 24
Testing effectiveness (Phase 2)Ended earlyNCT04497038
What this trial is testing

Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy

Who this might be right for
Advanced Adult Hepatocellular Carcinoma
University of Michigan Rogel Cancer Center 3
Early research (Phase 1)Not Yet RecruitingNCT07550634
What this trial is testing

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

Who this might be right for
Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B)Hepatic Insufficiency (MeSH ID: D048550)
MindRank AI Ltd 32
Early research (Phase 1)Study completedNCT02507765
What this trial is testing

Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Child-Pugh Class AChild-Pugh Class BStage IIIA Hepatocellular Carcinoma+4 more
Ohio State University Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT02128958
What this trial is testing

Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Can-Fite BioPharma 78